Shimizu Kouhei, Inuzuka Hiroyuki, Tokunaga Fuminori
Department of Medical Biochemistry, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan.
Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston MA02215, USA.
Semin Cancer Biol. 2025 Jan;108:1-16. doi: 10.1016/j.semcancer.2024.11.001. Epub 2024 Nov 16.
Cellular senescence is a state of permanent proliferative arrest that occurs in response to DNA damage-inducing endogenous and exogenous stresses, and is often accompanied by dynamic molecular changes such as a senescence-associated secretory phenotype (SASP). Accumulating evidence indicates that age-associated increases in the upstream and downstream signals of regulated cell death, including apoptosis, necroptosis, pyroptosis, and ferroptosis, are closely related to the induction of cellular senescence and its phenotype. Furthermore, elevated levels of pro-inflammatory SASP factors with aging can be both a cause and consequence of several cell death modes, suggesting the reciprocal effects of cellular senescence and cells undergoing regulated cell death. Here, we review the critical molecular pathways of the regulated cell death forms and describe the crosstalk between aging-related signals and cancer. In addition, we discuss how targeting regulated cell death could be harnessed in therapeutic interventions for cancer. ABBREVIATIONS: Abbreviations that are not standard in this field are defined at their first occurrence in the article and are used consistently throughout the article.
细胞衰老一种永久性增殖停滞状态,其发生是对诱导DNA损伤的内源性和外源性应激的反应,并且常伴有动态分子变化,如衰老相关分泌表型(SASP)。越来越多的证据表明,与年龄相关的调节性细胞死亡(包括凋亡、坏死性凋亡、焦亡和铁死亡)上下游信号的增加与细胞衰老及其表型的诱导密切相关。此外,随着衰老,促炎SASP因子水平升高可能是几种细胞死亡模式的原因和结果,这表明细胞衰老与经历调节性细胞死亡的细胞之间存在相互作用。在此,我们综述了调节性细胞死亡形式的关键分子途径,并描述了衰老相关信号与癌症之间的相互作用。此外,我们讨论了如何在癌症治疗干预中利用靶向调节性细胞死亡。缩写:本文中不标准的缩写在首次出现时进行定义,并在全文中一致使用。